Clinical trial
The Aim is to Estimate the Total Amount of Insulin-producing Cells in the…
NCT00280085 · Pfizer, Industry · Terminated
Key facts
| NCT number | NCT00280085 |
|---|---|
| Title | The Aim is to Estimate the Total Amount of Insulin-producing Cells in the Pancreas by MRI. |
| Official title | Pancreatic Beta-Cell Mass And Function Quantification By Means Of Perfusion Imaging |
| Lead sponsor | Pfizer, Industry |
| Collaborators | Yale University |
| Status | Terminated |
| Study type | Interventional |
| Conditions | Diabetes Mellitus |
| Intervention type | Drug, Procedure |
| Interventions | MR imaging, Glucose clamp, Arginine |
| Enrollment | 29 |
| Start date | Dec 1, 2005 |
| Completion | Jul 1, 2007 |
| First posted | Jan 20, 2006 |
| Last update posted | Aug 7, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: